Author:
Susarla Srinivas M.,Jacobsen Christina M.,Abramowicz Shelly
Reference72 articles.
1. Kaban LB, Dodson TB. Management of giant cell lesions. Int J Oral Maxillofac Surg. 2006;35(11):1074–5.
2. Papadaki ME, Troulis MJ, Kaban LB. Advances in diagnosis and management of fibro-osseous lesions. Oral Maxillofac Surg Clin North Am. 2005;17(4):415–34.
3. Chuong R, Kaban LB, Kozakewich H, Perez-Atayde A. Central giant cell lesions of the jaws: a clinicopathologic study. J Oral Maxillofac Surg. 1986;44(9):708–13.
4. Neville BW, Damm DD, Allen CM, Bouquot JE. Giant cell lesions. In: Oral and maxillofacial pathology, Neville, Damm, Allen, Bouquot editors. New York: WB Saunders; 2004, pp. 611–620.
5. Susarla SM, August M, Dewsnup N, Faquin WC, Kaban LB, Dodson TB. CD34 staining density predicts giant cell tumor clinical behavior. J Oral Maxillofac Surg. 2009;67(5):951–6.